As Canada enters 2026, a profound shift is occurring within the medical community regarding the treatment of gender-distressed youth. Dr. Karine Khatchadourian, an Ottawa-based pediatric endocrinologist and a pioneer in the field, is leading a growing movement of clinicians calling for a rigorous reassessment of the evidence supporting medical transitions for minors. In a recent presentation at the University of Alberta, Khatchadourian highlighted that the current clinical landscape resides in a “consequential grey zone” where contradictory findings make it difficult to predict long-term patient outcomes. This article explores why prominent Canadian doctors are moving away from the “just affirm” model toward a more holistic, evidence-backed approach that prioritizes mental health over immediate medical intervention.
- Evidence Uncertainty: Recent systematic reviews characterize the evidence for puberty blockers as “threadbare” and of “very low certainty.”
- Demographic Shift: Clinics are seeing a surge in natal females with no childhood history of distress, often influenced by social media.
- Clinical Pivot: Leading specialists now advocate for a mental-health-first approach, reserving medical intervention for the most persistent cases.
To understand the current tension in Canadian healthcare, one must look at the evolution of pediatric gender medicine. For years, the “affirming care” model—which prioritizes a child’s self-declared identity—was the gold standard across North American clinics. This approach was largely based on the “Dutch Protocol,” developed in the 1990s for a specific group of biological males with lifelong gender dysphoria. However, the patient profile has changed radically over the last decade, leaving doctors to question if old protocols still apply to today’s complex cases.
Transitions between sections are becoming more frequent as doctors share their concerns privately. While the Canadian Paediatric Society continues to endorse affirming care, individual practitioners are increasingly vocal about the lack of robust data. The stakes are high, as clinicians fear that a failure to adapt to new evidence could lead to a generation of youth facing irreversible physical changes without guaranteed psychological benefits.
Why are Canadian doctors questioning the evidence for gender-affirming care?
The primary driver for this clinical pivot is the lack of high-quality data. Dr. Gordon Guyatt, a world-renowned scientist at McMaster University, recently co-authored systematic reviews that sent shockwaves through the medical community. Using the GRADE scoring system, researchers found that the evidence supporting puberty blockers is of such low certainty that it is impossible to definitively state whether they are helpful or harmful in the long term.
Dr. Khatchadourian, who has treated nearly 300 gender-distressed children since 2014, now challenges the medicalization of the majority of youth presenting to clinics. “The message to patients, providers, and the public has to include that what we’re seeing now with the data is this uncertainty of the evidence,” she stated. This transparency is vital for informed consent, particularly when dealing with treatments that can lead to permanent infertility.
The British Medical Journal has recently highlighted these gaps in evidence, with editorial leadership describing the current research base as insufficient to answer critical questions about patient safety and efficacy. This lack of certainty has prompted countries like the United Kingdom, Sweden, and Finland to pull back on medical interventions for minors, focusing instead on psychological support.
How have changing demographics impacted clinical outcomes?
A significant portion of the debate centers on the “new cohort” of patients. Ten years ago, clinics primarily saw biological males with early-onset distress. Today, approximately 70 per cent of patients are natal females who often present with co-occurring conditions such as autism, depression, and anxiety. Many of these individuals had no history of gender incongruence during childhood, appearing instead to develop distress during or after puberty.
“It’s so hard to know when you see a patient how much of this story is really that person’s story and how much is based on the influence of peers and social media,” Khatchadourian noted.
Social media influence and peer contagion are now recognized as potential factors in the rise of non-binary identities among adolescents. Dr. Laura Targownik, a professor of medicine at the University of Toronto, suggests that in the pre-social media era, these feelings might have been transient. Now, youth can instantly connect with online communities that frame social disconnection as a need for medical transition, potentially bypassing necessary mental health diagnostic work.
What are the implications for the future of Canadian healthcare?
The shift toward caution suggests a future where mental health assessments are mandatory rather than optional. Currently, data indicates that only four out of ten gender clinics in Canada require a psychiatric or psychological assessment before starting medical treatments. Specialists like Khatchadourian are now advocating for a national review to ensure that Canadian practices align with the emerging international consensus on risk management.
This does not mean the end of gender care, but rather a refinement of what “care” entails. A more holistic approach involves supporting youth through identity development without immediately resorting to pharmaceuticals. For many clinicians, the goal is to address the underlying distress—whether it stems from trauma, neurodivergence, or dysphoria—with the most appropriate tool for the individual case.
The role of clinical rigour and long-term data
As the field evolves, the demand for “receipts” or long-term outcome data is growing. Government leaders and medical boards are increasingly asking for proof that transitioned youth are thriving five to ten years post-intervention. Without this data, doctors feel they are “changing trajectories” for youth based on limited information.
Clinicians are also calling for more inclusive discussions that involve de-transitioners—individuals who regret their medical transition. Understanding why some patients thrive while others regret their decisions is essential for developing predictive models that can guide future treatment. This rigour is necessary to rebuild public trust, which some experts describe as being in “free fall” across the political spectrum.
The evolution of doctors like Khatchadourian demonstrates that medical science is never settled. By prioritizing data over ideology, Canadian providers can ensure that the most vulnerable patients receive the nuanced, cautious care they deserve. Moving forward, the focus will likely remain on integrating comprehensive mental health support with a high-level-of-risk approach to medical interventions, ensuring that every child’s long-term well-being is the primary measure of clinical success.
